Recruiting

Gastrointestinal Symptoms

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06927011

Conditions

Colon Cancer

Eligibility Criteria

Sex: All

Age: 20 - 70+

Healthy Volunteers: Not accepted

Interventions

Capscan

Study Details

Brief summary:

The goal of this clinical research study is to learn about gastrointestinal symptoms in participants who have undergone SC or RC and their impact on the quality of life of these participants.

Conditions

Colon Cancer

Study ID

NCT06927011

Start date

Oct 31, 2025

Status verified date

Jul, 2026

Completion date

Dec 30, 2028

Anticipated

Primary completion date

Dec 30, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 20 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Both men and women of all races and ethnic groups are eligible for this trial who meet the above criteria.

Exclusion Criteria:

  • Children will not be enrolled in this study.
  • Pregnant women will not be enrolled in this study.
  • Cognitively impaired subjects will not be enrolled in this study.

Study Design

Enrollment

20 participants

Anticipated

Interventions and Outcome Measures

Arms

Colon Cancer

Participants will be asked to swallow 2 small devices (called Capscan), which will collect samples of intestinal fluid as they move through participants small intestine and colon. This device is not FDA approved but has been deemed to have no significant risk. The investigator can explain how it is designed to work. Participants will also answer surveys about participants quality of life.

Participants in this study will be over after all study procedures are completed.

Interventions

Capscan

Participants will be asked to swallow 2 small devices (called Capscan), which will collect samples of intestinal fluid as they move through participants small intestine and colon. This device is not FDA approved but has been deemed to have no significant risk. The investigator can explain how it is designed to work. Participants will also answer surveys about participants quality of life.

Participants in this study will be over after all study procedures are completed.

Primary outcome measure

  • Overall Survival (OS) [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts and Locations

Central contacts

Anusha Thomas, MBBS

(713) 794-1439asthomas1@mdanderson.org

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Anusha Thomas, MBBS

713-794-1439asthomas1@mdanderson.org

Principal Investigator:

Anusha Thomas, MBBS

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jul 16, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-07-16.